Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report
Silvio Ligia, Emilia Scalzulli, Ida Carmosino, Giovanna Palumbo, Maria Chiara Molinari, Rebecca Poggiali, Alessandro Costa, Maria Laura Bisegna, Maurizio Martelli, Massimo Breccia · 2024
Read Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report by Silvio Ligia, Emilia Scalzulli, Ida Carmosino, Giovanna Palumbo, Maria Chiara Molinari, Rebecca Poggiali, Alessandro Costa, Maria Laura Bisegna, Maurizio Martelli, Massimo Breccia (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10803620.txt.
Description
Silvio Ligia and co-authors report a hard case of polycythemia vera in a study published in 2023. The blood disorder struck a girl who was three when diagnosed in 2001, flooding her with red cells and enlarging her spleen. Bloodletting, hydroxyurea, and older interferon each failed to hold her counts or ease her symptoms.
Genetic work found the standard driver mutation plus a rare second variant in the same gene, a pairing that may explain the stubborn course. In 2023 she started a modern long acting interferon. Her blood values improved and symptoms eased. The authors argue the second mutation deserves attention in young, treatment resistant patients, and that the new drug merits wider use.
Catalog record
| CREATOR | Silvio Ligia, Emilia Scalzulli, Ida Carmosino, Giovanna Palumbo, Maria Chiara Molinari, Rebecca Poggiali, Alessandro Costa, Maria Laura Bisegna, Maurizio Martelli, Massimo Breccia |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |